Recombinant PR3 Glycosylation Mutant

<strong>Recombinant PR3 Glycosylation Mutant</strong>_x000D_ <strong>Catalog number:</strong> B2015065_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 29000_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20° C_x000D_ <strong>Keywords:</strong> rPR3, HEK293 Cells, Glycosylation Mutant_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, Zhao C, Zhang Q, Liu H, Nie L, Qin H, Wang M, Lu Q, Li X, Sun Q, Liu J, Zhang L, Li X, Huang W, Wang Y. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity Cell. 2020 Sep 3;182(5):1284-1294.e9._x000D_ 2: Kitajima T, Xue W, Liu YS, Wang CD, Liu SS, Fujita M, Gao XD. Construction of green fluorescence protein mutant to monitor STT3B-dependent N-glycosylation FEBS J. 2018 Mar;285(5):915-928._x000D_ 3: Potelle S, Morelle W, Dulary E, Duvet S, Vicogne D, Spriet C, Krzewinski-Recchi MA, Morsomme P, Jaeken J, Matthijs G, De Bettignies G, Foulquier F. Glycosylation abnormalities in Gdt1p/TMEM165 deficient cells result from a defect in Golgi manganese homeostasis Hum Mol Genet. 2016 Apr 15;25(8):1489-500._x000D_ 4: Nakamura Y, Aizawa C, Kawata H, Nakanishi T. N-glycosylation modifies prostaglandin E(2) uptake by reducing cell surface expression of SLCO2A1 Prostaglandins Other Lipid Mediat. 2023 Apr;165:106714._x000D_ 5: Klaver E, Zhao P, May M, Flanagan-Steet H, Freeze HH, Gilmore R, Wells L, Contessa J, Steet R. Selective inhibition of N-linked glycosylation impairs receptor tyrosine kinase processing Dis Model Mech. 2019 Jun 5;12(6):dmm039602._x000D_ 6: Uemura T, Ito S, Ohta Y, Tachikawa M, Wada T, Terasaki T, Ohtsuki S. Abnormal N-Glycosylation of a Novel Missense Creatine Transporter Mutant, G561R, Associated with Cerebral Creatine Deficiency Syndromes Alters Transporter Activity and Localization Biol Pharm Bull. 2017;40(1):49-55._x000D_ 7: Hwang YH, Tani M, Nakagawa T, Okino N, Ito M. Subcellular localization of human neutral ceramidase expressed in HEK293 cells Biochem Biophys Res Commun. 2005 May 27;331(1):37-42._x000D_ 8: Fan HD, Chen SP, Sun YX, Xu SH, Wu LJ. Seipin mutation at glycosylation sites activates autophagy in transfected cells via abnormal large lipid droplets generation Acta Pharmacol Sin. 2015 Apr;36(4):497-506._x000D_ 9: Nagaoka K, Hanioka N, Ikushiro S, Yamano S, Narimatsu S. The effects of N-glycosylation on the glucuronidation of zidovudine and morphine by UGT2B7 expressed in HEK293 cells Drug Metab Pharmacokinet. 2012;27(4):388-97._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/31635148">10: Wiedmann F, Schlund D, Faustino F, Kraft M, Ratte A, Thomas D, Katus HA, Schmidt C. N-Glycosylation of TREK-1/hK(2P)2.1 Two-Pore-Domain Potassium (K(2P)) Channels Int J Mol Sci. 2019 Oct 20;20(20):5193. </a>_x000D_ _x000D_ <strong>Products Related to Recombinant PR3 Glycosylation Mutant can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>